diphenyleneiodonium and Retinopathy of Prematurity
diphenyleneiodonium has been researched along with Retinopathy of Prematurity in 1 studies
diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.
Retinopathy of Prematurity: A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Tawfik, A | 1 |
Sanders, T | 1 |
Kahook, K | 1 |
Akeel, S | 1 |
Elmarakby, A | 1 |
Al-Shabrawey, M | 1 |
Other Studies
1 other study available for diphenyleneiodonium and Retinopathy of Prematurity
Article | Year |
---|---|
Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase.
Topics: Acetophenones; Animals; Blotting, Western; Cell Culture Techniques; Diabetes Mellitus, Experimental; | 2009 |